Moderate-Dose Hydroxyurea for Primary Prevention of Strokes in Nigerian Children with Sickle Cell Disease: Final Results of the SPIN Trial
AUTHORS
- PMID: 32510680 [PubMed].
ABSTRACT
Tags: faculty publications 2020
Tags: faculty publications 2020
©
Vanderbilt University · All rights reserved. Site Development: Digital Strategies (Division of Communications)
Vanderbilt University is committed to the principle of equal opportunity. Vanderbilt University does not discriminate against individuals on the basis of their race, sex, sexual orientation, gender identity, religion, color, national or ethnic origin, age, disability, military service, or genetic information in its administration of educational policies, programs, or activities; admissions policies; scholarship and loan programs; athletic or other University-administered programs; or employment. Accessibility information.
Vanderbilt®, Vanderbilt University®, V Oak Leaf Design®, Star V Design® and Anchor Down® are trademarks of The Vanderbilt University